Future perspective of clinical usefulness of metabolic and mitochondrial heterogeneity in triple-negative breast cancers
{{output}}
Triple-negative breast cancer (TNBC) is best characterized by high aggressiveness and significant biological heterogeneity. Although the current TNBC clinical trials include genomic biomarkers to stratify treatment arms, they are still limited by metabolic het... ...
